Trial · NCT03297294
Adverse events75
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 75
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Gamma-glutamyltransferase increased | Investigations | EMA401 100mg BID DB | 4 | 69 | |
| other | Gamma-glutamyltransferase increased | Investigations | Placebo BID DB | 1 | 66 | |
| other | Gamma-glutamyltransferase increased | Investigations | EMA401 100mg BID -> EMA401 100mg BID TW | 0 | 14 | |
| other | Gamma-glutamyltransferase increased | Investigations | EMA401 100mg BID -> Placebo BID TW | 0 | 12 | |
| other | Gamma-glutamyltransferase increased | Investigations | Placebo BID -> Placebo BID TW | 0 | 26 | |
| other | Lipase increased | Investigations | EMA401 100mg BID DB | 6 | 69 | |
| other | Lipase increased | Investigations | Placebo BID DB | 0 | 66 | |
| other | Lipase increased | Investigations | EMA401 100mg BID -> EMA401 100mg BID TW | 1 | 14 | |
| other | Lipase increased | Investigations | EMA401 100mg BID -> Placebo BID TW | 0 | 12 | |
| other | Lipase increased | Investigations | Placebo BID -> Placebo BID TW | 0 | 26 | |
| other | Headache | Nervous system disorders | EMA401 100mg BID DB | 4 | 69 | |
| other | Headache | Nervous system disorders | Placebo BID DB | 4 | 66 | |
| other | Headache | Nervous system disorders | EMA401 100mg BID -> EMA401 100mg BID TW | 0 | 14 | |
| other | Headache | Nervous system disorders | EMA401 100mg BID -> Placebo BID TW | 0 | 12 | |
| other | Headache | Nervous system disorders | Placebo BID -> Placebo BID TW | 0 | 26 | |
| other | Hypertension | Vascular disorders | EMA401 100mg BID DB | 1 | 69 | |
| other | Hypertension | Vascular disorders | Placebo BID DB | 2 | 66 | |
| other | Hypertension | Vascular disorders | EMA401 100mg BID -> EMA401 100mg BID TW | 0 | 14 | |
| other | Hypertension | Vascular disorders | EMA401 100mg BID -> Placebo BID TW | 1 | 12 | |
| other | Hypertension | Vascular disorders | Placebo BID -> Placebo BID TW | 0 | 26 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03297294/events?page=2